McNeil Consumer & Specialty Pharmaceuticals clinical trials
Formerly part of Johnson & Johnson, Aug 23, 2023 · source ↗
The registry lists 12 studies whose lead sponsor is McNeil Consumer & Specialty Pharmaceuticals. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 1, 2011.
Before and after it left Johnson & Johnson
- First submitted before McNeil Consumer & Specialty Pharmaceuticals left Johnson & Johnson
- 12
- First submitted after McNeil Consumer & Specialty Pharmaceuticals left Johnson & Johnson
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.12 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 12 of 12. All Johnson & Johnson studies →
- An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional RegimenCompletedNCT00320580Phase 2
Sponsor listed in the registry: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. · First submitted before McNeil Consumer & Specialty Pharmaceuticals left Johnson & Johnson
- The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia NervosaCompletedNCT00320567Phase 2
Sponsor listed in the registry: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. · First submitted before McNeil Consumer & Specialty Pharmaceuticals left Johnson & Johnson
- An Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Inflammation of the Prostate GlandCompletedNCT00236990Phase 2
Sponsor listed in the registry: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. · First submitted before McNeil Consumer & Specialty Pharmaceuticals left Johnson & Johnson
- A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity DisorderCompletedNCT00326391Phase 3
Sponsor listed in the registry: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. · First submitted before McNeil Consumer & Specialty Pharmaceuticals left Johnson & Johnson
- Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity DisorderCompletedNCT00866996Phase 4
Sponsor listed in the registry: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. · First submitted before McNeil Consumer & Specialty Pharmaceuticals left Johnson & Johnson
- An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms.CompletedNCT00338624Phase 3
Sponsor listed in the registry: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. · First submitted before McNeil Consumer & Specialty Pharmaceuticals left Johnson & Johnson
- A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity DisorderCompletedNCT00326300Phase 3
Sponsor listed in the registry: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. · First submitted before McNeil Consumer & Specialty Pharmaceuticals left Johnson & Johnson
- An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat MalabsorptionCompletedNCT00217204Phase 2
Sponsor listed in the registry: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. · First submitted before McNeil Consumer & Specialty Pharmaceuticals left Johnson & Johnson
- Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or NasopharynxCompletedNCT00051441Phase 3
Sponsor listed in the registry: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. · First submitted before McNeil Consumer & Specialty Pharmaceuticals left Johnson & Johnson
- An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended RegimenCompletedNCT00344383Phase 2
Sponsor listed in the registry: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. · First submitted before McNeil Consumer & Specialty Pharmaceuticals left Johnson & Johnson
- An Effectiveness and Safety Study of Cyclobenzaprine HCl Alone or in Combination With Ibuprofen for Acute Back or Neck Muscle Pain With Muscle SpasmCompletedNCT00246389Phase 4
Sponsor listed in the registry: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. · First submitted before McNeil Consumer & Specialty Pharmaceuticals left Johnson & Johnson
- An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity DisorderCompletedNCT00249353Phase 3
Sponsor listed in the registry: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. · First submitted before McNeil Consumer & Specialty Pharmaceuticals left Johnson & Johnson